Wednesday, November 04, 2026 11:01 AM ET
15 minutes ago
Midterm Election Day recap: Democrats flip Senate and House in stunning victory7 hours ago
Dow rallies 1,000 points as political risk eases after resounding Democratic victory in U.S. midterms: Live updates15 minutes ago
Analysis: The Democrats have one chance to extract concessions from Trump. Markets will hate it15 minutes ago
Trump hammers Fox News, blaming network for GOP losses as ratings slide15 minutes ago
CVS to split off drugstore business in major breakup of healthcare giant; shares fall 10%1 hour ago
Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook5 hours ago
Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO8 hours ago
Midterm elections could jolt stocks as Democrats look poised to sweep Congress12 hours ago
A biotech's high-stakes cancer bet just paid off and its shares doubled1 day ago
Jim Cramer says lower oil prices are giving stocks a boost. Can it last?1 day ago
Stocks started the week higher but ended in despair. Our take on the big reversal1 day ago
Cramer's week ahead: Expect more volatility as tech earnings, midterms loom4 days ago
Gen Z is ditching bars for run clubs — and finding more than friends along the way5 days ago
A pharma major is touting an MS drug to ease patent-cliff fears5 days ago
West Pharma: More than a GLP-1 play. The case for further upside5 days ago
Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx5 days ago
Merck tops estimates, hikes profit outlook on strength of injectable Keytruda5 days ago
Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand6 days ago
GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers6 days ago
Measles resurgence exposes deeper weaknesses in U.S. public health, experts say7 days ago
Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock8 days ago
Amgen says drug combo slashes risk of death by 58% in patients with lung cancer8 days ago
Doctors call Moderna, Merck's cancer vaccine data a major advancement11 days ago
Moderna shares plunge after cancer vaccine data leaks — despite positive results12 days ago
New bipartisan bill aims to speed up clinical trials for rare disease treatments13 days ago
Novo's CagriSema obesity drug shows 25% weight loss in women in analysis13 days ago
Sickle cell gene therapies offer new hope, but access remains a major challenge19 days ago
Here's our monthly update on our 32 stocks, including 2 more names to buy19 days ago
Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time19 days ago
What Maven CEO Kate Ryder tells her kids every day amid AI education threat20 days ago
Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost20 days ago
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs21 days ago
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock22 days ago
Jim Cramer week ahead: Bank earnings, ASML and TSMC22 days ago
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come26 days ago
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday27 days ago